Using morpholinos to control gene expression

Current Protocols in Molecular Biology

Volumn , Issue SUPPL. 83, 2008, Pages

  Moulton, Jon D ^a   Yan, Yi Lin ^b  

^a Gene Tools LLC   (United States)

^b UNIVERSITY OF OREGON   (United States)

Author keywords

Antisense; Knockdown; Morpholino; Oligo; Splicing; Xenopus; Zebrafish

Indexed keywords

COMPLEMENTARY RNA; MESSENGER RNA; MICRORNA; MORPHOLINE DERIVATIVE; MORPHOLINO OLIGONUCLEOTIDE; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; AGAROSE;

ANALYTIC METHOD; BASE PAIRING; BINDING AFFINITY; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENE TARGETING; KNOCKOUT GENE; MACROMOLECULE; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA BINDING; RNA PROCESSING; RNA SEQUENCE; RNA SPLICING; RNA TRANSLATION; TRANSLATION REGULATION; ULTRAVIOLET SPECTROPHOTOMETRY; ARTICLE; CALIBRATION; CLINICAL PROTOCOL; CONCENTRATION (PARAMETERS); EMBRYO CULTURE; GENE SILENCING; INCUBATION TEMPERATURE; INTRACELLULAR TRANSPORT; LIGHT ABSORPTION; MICROINJECTOR; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; SOLUTION AND SOLUBILITY; ULTRAVIOLET RADIATION;

DANIO RERIO;

EID: 58849118461     PISSN: 19343639     EISSN: 19343647     Source Type: Journal    
DOI: 10.1002/0471142727.mb2608s83     Document Type: Review

References (78)

1. Aboul-ela, F., Koh, D., Tinoco, I. Jr., and Martin, F.H. 1985. Base-basemismatches. Thermodynamics of double helix formation for dCA3XA3G + dCT3YT3G (X, Y = A,C,G,T). Nucleic Acids Res. 13:4811-4824.
2. Alonso, M., Stein, D.A., Thomann, E., Moulton, H.M., Leong, J.C., Iversen, P., and Mourich, D.V. 2005. Inhibition of infectious haematopoietic necrosis virus in cell cultures with peptideconjugated morpholino oligomers. J. Fish Dis. 28:399-410.
3. Bruno, I.G., Jin, W., and Cote, G.J. 2004. Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements. Hum. Mol. Genet. 13:2409-2420.
4. Cerda, G.A., Thomas, J.E., Allende, M.L., Karlstrom, R.O., and Palma, V. 2006. Electroporation of DNA, RNA, and morpholinos into zebrafish embryos. Methods 39:207-211.
5. Cheong, C. and Moore, P.B. 1992. Solution structure of an unusually stable RNA tetraplex containing G- and U-quartet structures. Biochemistry 31:8406-8414.
6. Choi, W.Y., Giraldez, A.J., and Schier, A.F. 2007. Target protectors reveal dampening and balancing of nodal agonist and antagonist by miR-430. Science 318:271-274.
7. Deas, T.S., Binduga-Gajewska, I., Tilgner, M., Ren, P., Stein, D.A., Moulton, H.M., Iversen, P.L., Kauffman, E.B., Kramer, L.D., and Shi, P.Y. 2005. Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication. J. Virol. 79:4599-4609.
8. Draper, B.W., Morcos, P.A., and Kimmel, C.B. 2001. Inhibition of zebrafish fgf8 pre-mRNA splicing with Morpholino oligos: A quantifiable method for gene knockdown. Genesis 30:154-156.
9. Ekker, S.C. 2000. Morphants: A new systematic vertebrate functional genomics approach. Yeast 17:302-306.
10. Ekker, S.C. and Larson, J.D. 2001. Morphant technology in model developmental systems. Genesis 30:89-93.
11. Enterlein, S.,Warfield, K.L., Swenson, D.L., Stein, D.A., Smith, J.L., Gamble, C.S., Kroeker, A.D., Iversen, P.L., Bavari, S., and Muhlberger, E. 2006. VP35 knockdown inhibits ebola virus amplification and protects against lethal infection in mice. Antimicrob. Agents Chemother. 50:984-993.
12. Geller, B.L., Deere, J., Tilley, L., and Iversen, P.L. 2005. Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis. J. Antimicrob. Chemother. 55:983-988.
13. Giles, R.V., Spiller, D.G., Clark, R.E., and Tidd, D.M. 1999. Antisense Morpholino oligonucleotide analog induces missplicing of c-myc mRNA. Antisense Nucleic Acid Drug Dev. 9:213-220.
14. Hayashi, Y., Horibata, Y., Sakaguchi, K., Okino, N., and Ito, M. 2005. A sensitive and reproducible assay to measure the activity of glucosylceramide synthase and lactosylceramide synthase using HPLC and fluorescent substrates. Anal. Biochem. 345:181-186.
15. He, J., Liu, G., Zhang, S., Rusckowski, M., and Hnatowich, D.J. 2003. Pharmacokinetics in mice of four oligomer-conjugated polymers for amplification targeting. Cancer Biother. Radiopharm. 18:941-947.
16. He, J., Liu, G., Gupta, S., Zhang, Y., Rusckowski, M., and Hnatowich, D.J. 2004. Amplification targeting: A modified pretargeting approach with potential for signal amplification-proof of a concept. J. Nucl. Med. 45:1087-1095.
17. Heasman, J., Kofron, M., and Wylie, C. 2000. Betacatenin signaling activity dissected in the early Xenopus embryo: A novel antisense approach. Dev. Biol. 222:124-134.
18. Henderson, R.E., Kirkegaard, L.H., and Leonard, N.J. 1973. Reaction of diethylpyrocarbonate with nucleic acid components. Adenosinecontaining nucleotides and dinucleoside phosphates. Biochim. Biophys. Acta 294:356-364.
19. Howard, M.T., Gesteland, R.F., and Atkins, J.F. 2004. Efficient stimulation of site-specific ribosome frameshifting by antisense oligonucleotides. RNA 10:1653-1661.
20. Hudziak, R.M., Barofsky, E., Barofsky, D.F., Weller, D.L., Huang, S.B., and Weller, D.D. 1996. Resistance of Morpholino phosphorodiamidate oligomers to enzymatic degradation. Antisense Nucleic Acid Drug. Dev. 6:267-272.
21. Jubin, R. 2005. Optimizing electroporation conditions for intracellular delivery of Morpholino antisense oligonucleotides directed against the hepatitis C virus internal ribosome entry site. Methods Mol. Med. 106:309-322.
22. Jubin, R., Vantuno, N.E., Kieft, J.S., Murray, M.G., Doudna, J.A., Lau, J.Y., and Baroudy, B.M. 2000. Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding. J. Virol. 74:10430-10437.
23. Kamachi, Y., Okuda, Y., and Kondoh, H. 2008. Quantitative assessment of the knockdown efficiency of Morpholino antisense oligonucleotides in zebrafish embryos using a luciferase assay. Genesis 46:1-7.
24. Kang, H., Chou, P.J., Johnson, W.C. Jr., Weller, D., Huang, S.B., and Summerton, J.E. 1992. Stacking interactions ofApAanalogueswith modified backbones. Biopolymers 32:1351-1363.
25. Khokha, M.K., Chung, C., Bustamante, E.L., Gaw, L.W., Trott, K.A., Yeh, J., Lim, N., Lin, J.C., Taverner, N., Amaya, E., Papalopulu, N., Smith, J.C., Zorn, A.M., Harland, R.M., and Grammer, T.C. 2002. Techniques and probes for the study of Xenopus tropicalis development. Dev. Dyn. 225:499-510.
26. Kimmel, C.B. and Law, R.D. 1985a. Cell lineage of zebrafish blastomeres. II. Formation of the yolk syncytial layer. Dev. Biol. 108:86-93.
27. Kimmel, C.B. and Law, R.D. 1985b. Cell lineage of zebrafish blastomeres. III. Clonal analyses of the blastula and gastrula stages. Dev. Biol. 108:94-101.
28. Kinney, R.M., Huang, C.Y., Rose, B.C., Kroeker, A.D., Dreher, T.W., Iversen, P.L., and Stein, D.A. 2005. Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with Morpholino oligomers. J. Virol. 79:5116-5128.
29. Kloosterman, W.P., Wienholds, E., Ketting, R.F., and Plasterk, R.H. 2004. Substrate requirements for let-7 function in the developing zebrafish embryo. Nucleic Acids Res. 32:6284-6291.
30. Kloosterman, W.P., Lagendijk, A.K., Ketting, R.F., Moulton, J.D., and Plasterk, R.H. 2007. Targeted inhibition ofmiRNA maturation with Morpholinos reveals a role formiR-375 in pancreatic islet development. PLoS Biol. 5:e203.
31. Kos, R., Tucker, R.P., Hall, R., Duong, T.D., and Erickson, C.A. 2003. Methods for introducing Morpholinos into the chicken embryo. Dev. Dyn. 226:470-477.
32. Lebedeva, I. and Stein, C.A. 2001. Antisense oligonucleotides: Promise and reality. Annu. Rev. Pharmacol. Toxicol. 41:403-419.
33. Li, Y.F. and Morcos, P.A. 2008. Design and synthesis of dendritic molecular transporter that achieves efficient in vivo delivery of morpholino antisense oligo. Bioconjug. Chem. In press.
34. Liu, G., He, J., Zhang, S., Liu, C., Rusckowski, M., and Hnatowich, D.J. 2002a. Cytosine residues influence kidney accumulations of 99mTclabeled Morpholino oligomers. Antisense Nucleic Acid Drug. Dev. 12:393-398.
35. Liu, G., Zhang, S., He, J., Liu, N., Gupta, S., Rusckowski, M., and Hnatowich, D.J. 2002b. The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc- Morpholinos in mice. Q. J. Nucl. Med. 46:233-243.
36. Mang'era, K.O., Liu, G., Yi,W., Zhang, Y., Liu, N., Gupta, S., Rusckowski, M., and Hnatowich, D.J. 2001. Initial investigations of 99mTc-labeled Morpholinos for radiopharmaceutical applications. Eur. J. Nucl. Med. 28:1682-1689.
37. Masaki, M., Izumi, M., Oshima, Y., Nakaoka, Y., Kuroda, T., Kimura, R., Sugiyama, S., Terai, K., Kitakaze, M., Yamauchi-Takihara, K., Kawase, I., and Hirota, H. 2005. Smad1 protects cardiomyocytes from ischemia-reperfusion injury. Circulation 111:2752-2759.
38. McCaffrey, A.P., Meuse, L., Karimi, M., Contag, C.H., and Kay, M.A. 2003.Apotent and specific Morpholino antisense inhibitor of hepatitis C translation in mice. Hepatology 38:503-508.
39. McClorey, G., Moulton, H.M., Iversen, P.L., Fletcher, S., and Wilton, S.D. 2006. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Ther. 13:1373-1381.
40. Mellitzer, G., Hallonet, M., Chen, L., and Ang, S.L. 2002. Spatial and temporal 'knock down' of gene expression by electroporation of doublestranded RNA and Morpholinos into early postimplantation mouse embryos. Mech. Dev. 118:57-63.
41. Melton, A.A., Jackson, J., Wang, J., and Lynch, K.W. 2007. Combinatorial control of signalinduced exon repression by hnRNP L and PSF. Mol. Cell Biol. 27:6972-6984.
42. Monga, S.P., Monga, H.K., Tan, X., Mule, K., Pediaditakis, P., and Michalopoulos, G.K. 2003. Beta-catenin antisense studies in embryonic liver cultures: Role in proliferation, apoptosis, and lineage specification. Gastroenterology 124:202-216.
43. Morcos, P.A. 2001. Achieving efficient delivery of Morpholino oligos in cultured cells. Genesis 30:94-102.
44. Morcos, P.A. 2007. Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos. Biochem. Biophys. Res. Commun. 358:521-527.
45. Moulton, H.M. and Moulton, J.D. 2003. Peptideassisted delivery of steric-blocking antisense oligomers. Curr. Opin. Mol. Ther. 5:123-132.
46. Moulton, H.M. and Moulton, J.D. 2008. Antisense morpholino oligomers and their peptide conjugates. In Therapeutic Oligonucleotides (J. Kurreck, ed.) pp. 43-79. Royal Society of Chemistry, London. In press.
47. Moulton, H.M., Nelson, M.H., Hatlevig, S.A., Reddy, M.T., and Iversen, P.L. 2004. Cellular uptake of antisense Morpholino oligomers conjugated to arginine-rich peptides. Bioconjug. Chem. 15:290-299.
48. Nasevicius, A. and Ekker, S.C. 2000. Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 26:216-220.
49. Nelson, M.H., Stein, D.A., Kroeker, A.D., Hatlevig, S.A., Iversen, P.L., and Moulton, H.M. 2005. Arginine-rich peptide conjugation to Morpholino oligomers: Effects on antisense activity and specificity. Bioconjug. Chem. 16:959-966.
50. Neuman, B.W., Stein, D.A., Kroeker, A.D., Paulino, A.D., Moulton, H.M., Iversen, P.L., and Buchmeier, M.J. 2004. Antisense Morpholinooligomers directed against the 5′ end of the genome inhibit coronavirus proliferation and growth. J. Virol. 78:5891-5899.
51. Neuman, B.W., Stein, D.A., Kroeker, A.D., Churchill, M.J., Kim, A.M., Kuhn, P., Dawson, P., Moulton, H.M., Bestwick, R.K., Iversen, P.L., and Buchmeier, M.J. 2005. Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense Morpholino oligomers. J. Virol. 79:9665-9676.
52. Nutt, S.L., Bronchain, O.J., Hartley, K.O., and Amaya, E. 2001. Comparison of morpholino based translational inhibition during the development of Xenopus laevis and Xenopus tropicalis. Genesis 30:110-113.
53. Partridge, M., Vincent, A., Matthews, P., Puma, J., Stein, D., and Summerton, J. 1996. A simple method for delivering Morpholino antisense oligos into the cytoplasm of cells. Antisense Nucleic Acid Drug Dev. 6:169-175.
54. Prasadan, K., Daume, E., Preuett, B., Spilde, T., Bhatia, A., Kobayashi, H., Hembree, M., Manna, P., and Gittes, G.K. 2002. Glucagon is required for early insulin-positive differentiation in the developing mouse pancreas. Diabetes 51:3229-3236.
55. Riedel-Kruse, I.H., Muller, C., and Oates, A.C. 2007. Synchrony dynamics during initiation, failure, and rescue of the segmentation clock. Science 317:1911-1915.
56. Sazani, P., Kang, S.H., Maier, M.A., Wei, C., Dillman, J., Summerton, J., Manoharan, M., and Kole, R. 2001. Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs. Nucleic Acids Res. 29:3965-3974.
57. Sazani, P., Gemignani, F., Kang, S.H.,Maier, M.A., Manoharan, M., Persmark, M., Bortner, D., and Kole, R. 2002. Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat. Biotechnol. 20:1228-1233.
58. Scacheri, P.C., Rozenblatt-Rosen, O., Caplen, N.J., Wolfsberg, T.G., Umayam, L., Lee, J.C., Hughes, C.M., Shanmugam, K.S., Bhattacharjee, A., Meyerson, M., and Collins, F.S. 2004. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 101:1892-1897.
59. Schmajuk, G., Sierakowska, H., and Kole, R. 1999. Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake. J. Biol. Chem. 274:21783-21789.
60. Stancheva, I., Collins, A.L., Van Den Veyver, I.B., Zoghbi, H., and Meehan, R.R. 2003. A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. Mol. Cell. 12:425-435.
61. Stein, D., Foster, E., Huang, S.B., Weller, D., and Summerton, J. 1997. A specificity comparison of four antisense types: Morpholino, 2′-Omethyl RNA, DNA, and phosphorothioate DNA. Antisense Nucleic Acid Drug Dev. 7:151-157.
62. Stein, D.A., Skilling, D.E., Iversen, P.L., and Smith, A.W. 2001. Inhibition of Vesivirus infections in mammalian tissue culture with antisense Morpholino oligomers. Antisense Nucleic Acid Drug Dev. 11:317-325.
63. Stirchak, E.P., Summerton, J.E., and Weller, D.D. 1989. Uncharged stereoregular nucleic acid analogs: 2. Morpholino nucleoside oligomers with carbamate internucleoside linkages. Nucleic Acids Res. 17:6129-6141.
64. Summerton, J. 1999. Morpholino antisense oligomers: The case for an RNase Hindependent structural type. Biochim. Biophys. Acta 1489:141-158.
65. Summerton, J. 2004. Morpholinos and PNAs compared. Lett. Pept. Sci. 10:215-236.
66. Summerton, J. 2005. Endo-Porter: A novel reagent for safe, effective delivery of substances into cells. Ann. N.Y. Acad. Sci. 1058:1-14.
67. Summerton, J. and Weller, D. 1997. Morpholino antisense oligomers: Design, preparation, and properties. Antisense Nucleic Acid Drug Dev. 7:187-195.
68. Suwanmanee, T., Sierakowska, H., Fucharoen, S., and Kole, R. 2002. Repair of a splicing defect in erythroid cells from patients with betathalassemia/HbE disorder. Mol. Ther. 6:718-726.
69. Takahashi, M., Sato, K., Nomura, T., and Osumi, N. 2002. Manipulating gene expressions by electroporation in the developing brain of mammalian embryos. Differentiation 70:155-162.
70. Thummel, R., Bai, S., Sarras, M.P. Jr., Song, P., McDermott, J., Brewer, J., Perry, M., Zhang, X., Hyde, D.R., and Godwin, A.R. 2005. Inhibition of zebrafish fin regeneration using in vivo electroporation of Morpholinos against fgfr1 and msxb. Dev. Dyn. 235:336-346.
71. Tidd, D.M., Giles, R.V., Broughton, C.M., and Clark, R.E. 2001. Expression of c-myc is not critical for cell proliferation in established human leukemia lines. BMC Mol. Biol. 2:13.
72. Tucker, R.P. 2004. Antisense knockdown of the beta1 integrin subunit in the chicken embryo results in abnormal neural crest cell development. Int. J. Biochem. Cell Biol. 36:1135-1139.
73. Tyson-Capper, A.J. and Europe-Finner, G.N. 2006. Novel targeting of cyclooxygenase-2 (COX-2) pre-mRNAusing antisense morpholino oligonucleotides directed to the 3′ acceptor and 5′ donor splice sites of exon 4: Suppression of COX-2 activity in human amnion-derivedWISH and myometrial cells. Mol. Pharmacol. 69:796-804.
74. van den Born, E., Stein, D.A., Iversen, P.L., and Snijder, E.J. 2005. Antiviral activity of Morpholino oligomers designed to block various aspects of equine arteritis virus amplification in cell culture. J. Gen. Virol. 86:3081-3090.
75. Warfield, K.L., Swenson, D.L., Olinger, G.G., Nichols, D.K., Pratt, W.D., Blouch, R., Stein, D.A., Aman, M.J., Iversen, P.L., and Bavari, S. 2006. Gene-specific countermeasures against ebola virus based on antisense phosphorodiamidate morpholino oligomers. PLoS Pathog. 2:e1.
76. Westerfield, M. 2007. The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio), 5th ed. University of Oregon Press, Eugene, Oregon.
77. Yen, L., Svendsen, J., Lee, J.S., Gray, J.T., Magnier, M., Baba, T., D'Amato, R.J., and Mulligan, R.C. 2004. Exogenous control of mammalian gene expression through modulation of RNA selfcleavage. Nature 431:471-476.
78. Youngblood, D.S., Hatlevig, S.A., Hassinger, J.N., Iversen, P.L., and Moulton, H.M. 2007. Stability of cell-penetrating peptide-Morpholino oligomer conjugates in human serum and in cells. Bioconjug. Chem. 18:50-60.